Home > Boards > US Listed > Banking and Finance > Ladenburg Thalmann Financial Services Inc. (LTS)

The stock has corrected recently, and is now

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
investora2z Member Profile
 
Followed By 10
Posts 602
Boards Moderated 0
Alias Born 02/08/13
160x600 placeholder
Triad Advisors Successfully Recruits Hybrid Wealth Management Practice Strategic Wealth Advisors PR Newswire (US) - 11/21/2019 6:00:00 AM
Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option GlobeNewswire Inc. - 11/19/2019 5:35:00 PM
WeissLaw LLP Investigates Ladenburg Thalmann Financial Services Inc. PR Newswire (US) - 11/19/2019 1:06:00 PM
Yield10 Bioscience Announces Pricing of $10.75 Million Equity Offering GlobeNewswire Inc. - 11/15/2019 8:20:00 AM
Rowley Law PLLC is Investigating Proposed Acquisition of Ladenburg Thalmann Financial Services Inc. PR Newswire (US) - 11/12/2019 1:28:00 PM
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Ladenburg Thalmann Financial Services Inc. has obtained a Fair ... PR Newswire (US) - 11/12/2019 12:32:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:32:16 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 6:31:09 AM
Advisor Group And Ladenburg Thalmann Announce Merger To Create A Wealth Management Industry Leader With Nearly 11,500 Financi... PR Newswire (US) - 11/11/2019 7:35:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:54:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2019 8:06:20 AM
Ladenburg Reports Third Quarter 2019 Financial Results Business Wire - 11/8/2019 8:00:00 AM
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/4/2019 9:19:00 AM
KMS Financial Services Adds Patrick Funke & Associates PR Newswire (US) - 10/24/2019 6:00:00 AM
Ladenburg Institute Of Women & Finance Concludes 8th Annual Symposium To Create Opportunities And Build Community For Women A... PR Newswire (US) - 10/17/2019 6:00:00 AM
Securities America Announces That Knight Investments Group Has Joined Its Platform Business Wire - 10/8/2019 6:00:00 AM
Gladstone Capital Corporation Announces Notes Offering GlobeNewswire Inc. - 10/7/2019 9:02:31 AM
Triad Advisors Announces That Hybrid RIA Practice Mooney Lyons Financial Advisors Has Joined Its Platform PR Newswire (US) - 10/3/2019 6:00:00 AM
Ladenburg Thalmann Financial Services Inc. Confirms Series A Preferred Stock Monthly Dividends for Q4 2019 Business Wire - 10/1/2019 8:00:00 AM
Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering PR Newswire (US) - 9/30/2019 9:24:00 AM
Gordon Pointe Acquisition Corp. Enters into a Merger Agreement with HOF Village, LLC in Canton, Ohio PR Newswire (US) - 9/16/2019 7:11:00 PM
Ladenburg Wins Broker-Dealer Thought Leadership Award At Fifth Annual WealthManagement.com Industry Awards PR Newswire (US) - 9/16/2019 5:03:00 PM
investora2z   Saturday, 10/05/13 12:44:34 PM
Re: None
Post # of 138 
The stock has corrected recently, and is now about 15% below the 52 week high of $2.02 made in July. The next earnings could be an important trigger for the stock. It will determine the short term direction of the stock. If the company is able to post good numbers, then the upward momentum will resume and gain strength. The fundamentals have shown improvement recently, and the company seems to be close to achieving profitability on a net basis. The ttm revenues are around $684 million and the net loss is around $15 million. This compares well with the 2012 figures of $650 million and $16 million for revenues and net loss respectively. It indicates that the company may do better than 2012. In H1'13, the revenue were $381 million which is 20% above the $318 million in H1'12. The net loss also declined from $8 million to $6.4 million during the same period. The debt has reduced over the last couple of quarters, though the extinguishment has cost the company $3.8 million as a one time charge. In addition there may be recurring costs. Dr. Frost's support has been the real game changer for the sentiments about the company. Recently, several of his investments have done very well, and many like Biozone (BZNE) still have a lot of potential. LTS stock has not done as well as many of Dr. Frost's other stocks, but is still up 36% on a 52 week basis. However, as soon as the market begins to factor the possible turnaround, the stock may begin to do even better. The price to sales ratio is extremely low (0.47), and the price may catch up with the fundamentals soon. It is important that the improvement in fundamentals is consistent over the next few quarters. There have been some small insider purchases recently, and one needs to keep a watch on that before the earnings.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist